Abstract
Purpose
WHO grade II meningiomas behave aggressively, with recurrence rates as high as 60%. Although complete resection in low-grade meningiomas is associated with a relatively low recurrence rate, the impact of complete resection for WHO grade II meningiomas is less clear. We studied the association of extent of resection with overall and progression-free survivals in patients with WHO grade II meningiomas.
Methods
A retrospective database review was performed to identify all patients who underwent surgical resection for intracranial WHO grade II meningiomas at our institution between 1995 and 2019. Kaplan–Meier analysis was used to compare overall and progression-free survivals between patients who underwent gross total resection (GTR) and those who underwent subtotal resection (STR). Multivariable Cox proportional-hazards analysis was used to identify independent predictors of tumor recurrence and mortality.
Results
Of 214 patients who underwent surgical resection for WHO grade II meningiomas (median follow-up 53.4 months), 158 had GTR and 56 had STR. In Kaplan–Meier analysis, patients who underwent GTR had significantly longer progression-free (p = 0.002) and overall (p = 0.006) survivals than those who underwent STR. In multivariable Cox proportional-hazards analysis, GTR independently predicted prolonged progression-free (HR 0.57, p = 0.038) and overall (HR 0.44, p = 0.017) survivals when controlling for age, tumor location, and adjuvant radiation.
Conclusions
Extent of resection independently predicts progression-free and overall survivals in patients with WHO grade II meningiomas. In an era of increasing support for adjuvant treatment modalities in the management of meningiomas, our data support maximal safe resection as the primary goal in treatment of these patients.
Similar content being viewed by others
Data availability
De-identified raw data available upon request.
Code availability
Available upon request.
References
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21(Suppl 5):v1–v100. https://doi.org/10.1093/neuonc/noz150
Rogers L, Gilbert M, Vogelbaum MA (2010) Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 99(3):393–405. doi:https://doi.org/10.1007/s11060-010-0343-1
Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol 17(8):1166–1173. doi:https://doi.org/10.1093/neuonc/nov069
Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N (2013) The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119(2):475–481. doi:https://doi.org/10.3171/2012.12.JNS12414
Klinger DR, Flores BC, Lewis JJ, Hatanpaa K, Choe K, Mickey B, Barnett S (2015) Atypical meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 84(3):839–845. https://doi.org/10.1016/j.wneu.2015.04.033
Komotar RJ, Iorgulescu JB, Raper DM, Holland EC, Beal K, Bilsky MH, Brennan CW, Tabar V, Sherman JH, Yamada Y, Gutin PH (2012) The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg 117(4):679–686. doi:https://doi.org/10.3171/2012.7.JNS112113
Lam Shin Cheung V, Kim A, Sahgal A, Das S (2018) Meningioma recurrence rates following treatment: a systematic analysis. J Neurooncol 136(2):351–361. doi:https://doi.org/10.1007/s11060-017-2659-6
Mair R, Morris K, Scott I, Carroll TA (2011) Radiotherapy for atypical meningiomas. J Neurosurg 115(4):811–819. doi:https://doi.org/10.3171/2011.5.JNS11112
Nanda A, Bir SC, Konar S, Maiti T, Kalakoti P, Jacobsohn JA, Guthikonda B (2016) Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosci 31:112–121. doi:https://doi.org/10.1016/j.jocn.2016.02.021
Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D (2005) The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31(2):141–149. doi:https://doi.org/10.1111/j.1365-2990.2004.00621.x
Soni P, Li S, Sagar S, Prayson RA, Angelov L, Mohammadi AM, Barnett GH, Recinos PF, Kshettry VR (2020) Clear cell meningioma: a clinicopathologic study of a rare meningioma subtype in 35 patients. World Neurosurg. https://doi.org/10.1016/j.wneu.2020.05.120
Hou J, Kshettry VR, Selman WR, Bambakidis NC (2013) Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus 35(6):E2. doi:https://doi.org/10.3171/2013.8.FOCUS13301
Joshi KC, Raghavan A, Muhsen B, Hsieh J, Borghei-Razavi H, Chao ST, Barnett GH, Suh JH, Neyman G, Kshettry VR, Recinos PF, Mohammadi AM, Angelov L (2019) Fractionated Gamma Knife radiosurgery for skull base meningiomas: a single-institution experience. Neurosurg Focus 46(6):E8. doi:https://doi.org/10.3171/2019.3.FOCUS1963
Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20(1):22–39. doi:https://doi.org/10.1136/jnnp.20.1.22
Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129(2):337–345. doi:https://doi.org/10.1007/s11060-016-2181-2
Fernandez C, Nicholas MK, Engelhard HH, Slavin KV, Koshy M (2016) An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas. Adv Radiat Oncol 1(2):89–93. doi:https://doi.org/10.1016/j.adro.2016.03.001
Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH (2000) Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46(1):57–61. doi:https://doi.org/10.1016/s0360-3016(99)00349-1
Jo K, Park HJ, Nam DH, Lee JI, Kong DS, Park K, Kim JH (2010) Treatment of atypical meningioma. J Clin Neurosci 17(11):1362–1366. doi:https://doi.org/10.1016/j.jocn.2010.03.036
Park HJ, Kang HC, Kim IH, Park SH, Kim DG, Park CK, Paek SH, Jung HW (2013) The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115(2):241–247. doi:https://doi.org/10.1007/s11060-013-1219-y
Ros-Sanjuan A, Iglesias-Morono S, Carrasco-Brenes A, Bautista-Ojeda D, Arraez-Sanchez MA (2019) Atypical meningiomas: histologic and clinical factors associated with recurrence. World Neurosurg 125:e248–e256. https://doi.org/10.1016/j.wneu.2019.01.056
Wang YC, Chuang CC, Wei KC, Hsu YH, Hsu PW, Lee ST, Wu CT, Tseng CK, Wang CC, Chen YL, Jung SM, Chen PY (2015) Skull base atypical meningioma: long term surgical outcome and prognostic factors. Clin Neurol Neurosurg 128:112–116. doi:https://doi.org/10.1016/j.clineuro.2014.11.009
Zaher A, Abdelbari Mattar M, Zayed DH, Ellatif RA, Ashamallah SA (2013) Atypical meningioma: a study of prognostic factors. World Neurosurg 80(5):549–553. doi:https://doi.org/10.1016/j.wneu.2013.07.001
Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML, Norden AD, Beroukhim R, Reardon DA, Wen PY, Al-Mefty O, Arvold ND, Dunn IF, Alexander BM (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121(24):4376–4381. doi:https://doi.org/10.1002/cncr.29639
Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95(3):367–375. doi:https://doi.org/10.1007/s11060-009-9934-0
Palma L, Celli P, Franco C, Cervoni L, Cantore G (1997) Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86(5):793–800. doi:https://doi.org/10.3171/jns.1997.86.5.0793
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383. doi:https://doi.org/10.1016/0021-9681(87)90171-8
Abbassy M, Woodard TD, Sindwani R, Recinos PF (2016) An overview of anterior skull base meningiomas and the endoscopic endonasal approach. Otolaryngol Clin North Am 49(1):141–152. https://doi.org/10.1016/j.otc.2015.08.002
Borghei-Razavi H, Raghavan A, Eguiluz-Melendez A, Joshi K, Fernandez-Miranda JC, Kshettry VR, Recinos PF (2020) Anatomical variations in the location of veins draining into the anterior superior sagittal sinus: implications for the transbasal approach. Oper Neurosurg (Hagerstown) 18(6):668–675. https://doi.org/10.1093/ons/opz339
Cohen DM, Borghei-Razavi H, Kshettry VR, Recinos PF (2020) The endoscopic endonasal approach or microscopic transcranial approach for anterior skull base meningiomas-it is all about right indication rather than superiority. Acta Neurochir (Wien) 162(1):77–78. https://doi.org/10.1007/s00701-019-04080-3
Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A, Lo SS, Ishkanian F, Komotar RJ (2015) The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83(5):808–815. doi:https://doi.org/10.1016/j.wneu.2014.12.037
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Soni, P., Davison, M.A., Shao, J. et al. Extent of resection and survival outcomes in World Health Organization grade II meningiomas. J Neurooncol 151, 173–179 (2021). https://doi.org/10.1007/s11060-020-03632-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-020-03632-3